SOHO

17 MAY 2025

09:00 – 10:00

Oral Communications Sessions - Chairs: Handan Haydaroğlu Şahin

09:00 – 09:10

Flt3 Mutatıonal Analysıs In Acute Myeloıd Leukemıa

Rım Frıkha

09:10 – 09:20

Long-Term Outcomes Of Nıvolumab 40 Mg Vs 3 Mg/Kg In Relapsed/Refractory Classıc Hodgkın Lymphoma: A Matched Cohort Study

Lıudmıla Fedorova

09:20 – 09:30

Does Body Mass Index Affects Stem Cell Yıeld In Healthy Donors?

Uğur Hatipoğlu

09:30 – 09:40

Chronic Pancreatitis Induced By Nilotinib: A Case Of Drug-Related Pancreatic Toxicity İn Chronic Myeloid Leukemia

Naciye Nur Tozluklu

09:40 – 09:50

Prognostıc Sıgnıfıcance Of Neutrophıl And Monocyte Counts In Chronıc Lymphocytıc Leukemıa

Meryem Şener

09:50 – 10:00

Why Does Myeloid Malignancy Develop After Lymphoid Malignancy? What Triggers İt?

Gülşah Akyol

10:00 - 10:15

Introduction

10:15 - 11:25

ALL Session Chairs: Serdar Bedii Omay - Mesut Ayer

10:15 - 10:30

How Do I Treat Newly Diagnosed Ph-Negative ALL

Hagop Kantarjian

10:30 - 10:45

How Do I Treat R-R ALL

Elias Jabbour

10:45 - 11:00

Management of Ph-Like ALL and ETP

Sabina Chiaretti

11:00 - 11:15

How Do I Treat Ph-Positive ALL

Elias Jabbour

11:15 - 11:25

Q&A

11:25 - 11:55

Coffee Break With Poster Views Chairs: Didar Yanardağ Açık

PP - 01

Real-World Effıcacy And Safety Of Ruxolıtınıb In Steroıd-Refractory Graft-Versus-Host Dısease: A Multıcenter Retrospectıve Study From Turkey

Mehmet Bakırtaş

PP – 02

Jak Inhıbıtors In T-Cell Lymphomas, A Case-Based Perspectıve

Esra Pırınccı

PP – 03

Follıcular Lymphoma As An Etıology Of Chylous Ascıtes

Hatice Gözde Çilek

PP – 04

Burkıtt Leukemıa (All-L3) Presentıng Wıth Facıal Paralysıs And Ptosıs In An Elderly Patıent: A Rare Case

Songül Beskisiz Dönen

PP – 05

Mantle Cell Lymphoma And Cısplatın-Induced Hyponatremıa: A Case Report

Songül Beskisiz Dönen

PP – 06

A Case Of Nılotınıb Assocıated Acute Pancreatıtıs

Vehbi Demircan

PP – 07

A Case Of T-PLL Refractory To Multiple Treatments

Süleyman Arslan

PP - 08

Iron Defıcıency Anemıa: Study Of Causatıve And Assocıated Factors From The Sultanate Of Oman

Ikhlas Albusaıdı

CML Session Chairs: Leylagül Kaynar - Güven Yılmaz

11:55 - 12:10

How Do I Treat Newly Diagnosed CML

Hagop Kantarjian

12:10 - 12:25

How Do I Treat R-R CML

Elias Jabbour

12:25 - 12:40

TFR When and Where

Giuseppe Saglio

12:40 - 12:50

Q&A

12:50 - 13:50

LUNCH BREAK

AML Session Chairs: Rıdvan Ali - Şebnem İzmir Güner

13:50 - 14:05

How Do Treat Newly Diagnosed Young Fit AML

Naval Daver

14:05 - 14:20

How Do I Treat Older/Unfit AML

Tapan Kadia

14:20 - 14:35

Novel Targeted Therapies 

Naval Daver

14:35 - 14:50

Role of Allogeneic Stem Vell Transplantation in AML

Serdar Bedii Omay

14:50 - 15:05

MRD and Maintenance in AML

Tapan Kadia

15:05 - 15:15

Q&A

15:15 - 15:45

Coffee Break With Poster Views / Chairs: Müzeyyen Aslaner Ak

PP - 01

Incıdence And Rısk Factors Of Infectıous Complıcatıons In Patıents Wıth Acute Gvhd After Post-Transplant Cyclophosphamıde-Based Prophylaxıs

Aleksandr Siniaev

PP – 02

Outcome Of Haploidentical Hematopoietic Stem Cell Transplantation İn Resource Limited Setting

Khadıja Bano

PP – 03

Pre-Transplant Ganciclovir Prophylaxis To Prevent CMV Infections İn Allogeneic Hematopoietic Stem Cell Transplant Recipients

Khadıja Bano

PP – 04

Gılterıtınıb Experıence In Relapsed/Refractory Flt3-Mutated Aml Patıents After Allogeneıc Transplant: Two Cases

Serdar Bedii Omay

PP – 05

The Duality Of Myeloid Diseases: Langerhans Cell Histiocytosis İn A Patient With Primary Myelofibrosis

Mihriban Yıldırım

PP – 06

Cısplatın Induced Cardıomyopathy After Salvage Chemotherapy For Non-Hodgkın Lymphoma

Fehmi Hindilerden

PP – 07

A Case Of Prımary Cns Lymphoma Wıth Corpus Callosum Involvement And Memory Impaırment

Ali Turunç

PP - 08

A Case Of Achalasıa After Allogeneıc Haematopoıetıc Stem Cell Transplantatıon

Ali Turunç

CLL Session Chairs: Seçkin Çağırgan - Figen Atalay

15:45 - 16:00

How to Optmize Frontline Therapy in CLL

Nitin Jain

16:00 - 16:15

MRD in CLL: Ready For Primetime

Antonio Cuneo (Virtual)

16:15 – 16.30

How Do I Treat R-R CLL

Nitin Jain

16:30 – 16:40

Q&A

MDS Session Chairs:  Güven Çetin - Düzgün Özatlı

16:40 – 16:55

Biology of MDS and Revised Classification

Rami Komrokji

16:55 – 17:10

Updates on Low-Risk MDS

Guillermo Garcia-Manero (Virtual)

17:10 – 17:25

Updates on High-Risk MDS

Guillermo Garcia-Manero (Virtual)

17:25 – 17:35

Q&A

18 MAY 2025

08:00 - 09:00

Oral Communications Sessions - Chairs: Zahit Bolaman, Fahri Şahin

08:00-08:10

Retrospective Analysis Of Primary Breast Lymphomas: A Single Center Experience

Zehra Akşit Bozkına

08:10-08:20

Predıctors Of Response To Ruxolıtınıb Therapy In Patıents Wıth Myelofıbrosıs

Irına Turtanova

08:20-08:30

Bleedıng Wıthout Warnıng: The Hıdden Rısk Of Hydroxyurea Induced Wunderlıch Syndrome In Myeloprolıferatıve Dısorder

Veysel Erol

08:30-08:40

Venetoclax-Based Versus 7+3 Inductıon Therapy In Fıt Younger Adults Wıth Newly Dıagnosed Non-Cbf Aml

Dmıtrıı Zhogolev

08:40-08:50

Hope Or Hazard? The Safety Profıle Of Roxadustat In Anemıc Patıents

Ahmet Sarıcı

08:50-09:00

Does Neutrophıl-To- Lymphocyte Ratıo Predıct Overal Survıval In Prımary Myelofıbrosıs.

Elmir Guluyev

MPN Session Chairs: Mehmet Sönmez - Güray Saydam

09:00 - 09:15

Classification of MPN

Haifa Kathrin Al-Ali

09:15 - 09:30

Novel Strategies in MF

Rami Komrokji

09:30 - 09:45

How I Treat PV/ET

Tariq Mughal

09:45 - 09:55

Q&A

09:55 - 10:25

ALEXION SATALITE SYMPOSIUM

PNH and Eculizumab Treatment

 Chair : Orhan Ayyıldız               

Chair : Orhan Ayyıldız

Speaker : Mehmet Yılmaz

10:25 - 10:55

Coffee Break With Poster Views / Chairs: Güçhan Alanoğlu

PP - 01

Whıch Cancer Wıll Receıve Prıorıty Treatment: A Man Wıth Synchronous Hıgh-Grade Lymphoma And Non-Small Cell Lung Cancer

Ulvıyya Hasanzade

PP – 02

A Case Of Multıple Serıal Treatment-Resıstant Prımary Medıastınal B Cell Lymphoma Wıth Near Complete Response To Nıvolumab Plus Brentıxumab Vedotın

Ceren Uzunoğlu Güren

PP – 03

Wasp Venom Has A Kıllıng Effect On Leukemıc Cells

Zahit Bolaman

PP – 04

A Case Of Lung Cancer Mimicking Multiple Myeloma And Myelodysplastic Syndrome: A Diagnostic Challenge

Candaş Mumcu

PP – 05

A Rare Case Of Chronic Myeloid Leukemia With Myelofibrosis Transformation And Persistent Splenomegaly Refractory To Multiple Lines Of Therapy

Naciye Nur Tozluklu

PP – 06

A Rare Case Of Chronic Lymphocytic Leukemia With Subsequent Diagnosis Of Chronic Myeloid Leukemia: A Diagnostic And Therapeutic Challenge

Naciye Nur Tozluklu

PP – 07

The Significance Of Mild Cytopenia: A Case Of Low-Grade B-Cell Lymphoid Neoplasia Diagnosed After Five Years Of Unexplained Neutropenia

Feride Aslanca

MM Session Chairs:  Ayse Tulin Tuglular - Mehmet Sinan Dal

10:55 - 11:10

How I Treat Fit Newly Diagnosed MM

Angelo Maiolino (Virtual)

11:10 - 11:25

How I Treat Unfit Newly Diagnsoed MM

Claudio Cerhione

11:25 - 11:40

Management of R-R Disease

Angelo Maiolino (Virtual)

11:40 - 11:50

Q&A

NHL Session Chairs:  Orhan Ayyıldız - Mahmut Töbü

11:50 - 12:05

Updates on DLBCL

Massimo Federico

12:05 - 12:20

Updates on MCL

Elif Gülsüm Ümit

12:20 - 12:35

Updates on Follicular Lymphoma

Tayfur Toptaş

12:35 - 12:50

Updates on Hodgkin Disease

Valeh Huseynov

12:50 - 13:00

Q&A

13:00

CLOSING REMARKS

18 MAY 2025

14.30 - 14.40

OPENING REMARKS OF EHOC 2025

SESSION 1 - Opening Session

Chairs: Rudiger Hehlmann - Bülent Zülfikar

14.40 - 14.55

Mission to Mars: Radiation Risk For Interplanetary Travel

Robert Gale

14.55 - 15.10

Some Nobel Prizes That Shaped Hematology

Emin Kansu

15.10 - 15.30

History of Blood Transfussion

Tanju Atamer

15.30 - 15.45

History of Acute Lymphoblastic Leukemia

Dieter Hoelzer

15.45 - 16.00

From DigiBioPharma to NeXPharma: On the Brink of Digital and Biological Integration in Hematology (Pharma 4.9 → Pharma 5.0)

Birol Güvenç

16.00 - 16.15

The History of Chronic Myeloid Leukemia: From Arsenic to Asciminib

Rudiger Hehlmann

16.15 - 16.25

Q&A

16.25 - 16.50

COFFEE BREAK

SESSION 7 - Management of Chronic Lympoliratif Diseases & Indolent Lymphomas

CHAIRS: Gianluca Gaidano - Pelin Aytan

16.50 - 17.10

How To Manage CLL with Restricted Resources 

Gianluca Gaidano

17.10 - 17.30

New Drugs for CLL

Ahmad Ibrahim

17.30 - 17.50

How I Treat T-Cell Lymphoma

Anna Maria Sureda Balari(Virtual)

17.50 - 18.10

How I Treat Marginal Zone Lymphoma

Irina Panovska-Stavridis

18.10 - 18.25

How I Treat Follicular Lymphoma

Umut Yılmaz

Q&A

SESSION 8 - Management of Aggressive Lymphomas

CHAIRS: Khaled Halehleh - Vahap Okan

18.25 - 18.45

Novel Therapies for Relapsed/Refractory Aggressive Lymphomas

Huseyin Bekoz

18.45 - 19.05

Diffuse Large Cell Lymphomas with Restricted Resources

Suzana Krasniqi

19.05 - 19.25

Mentle Cell Lymphoma

Massimo Federico

19.25 - 19.45

Treatment for Hodgkin Lyphomass with Restricted Resources

Khaled Halahleh

19.45 - 20.00

Q&A

19 MAY 2025

07.30 - 08.30

Oral Communications Sessions

CHAIRS: Gamze Tanrıöver - Fatih Erbey

07:30 – 07:40

Neuron Specıfıc Enolase Posıtıve Ovarıan Intermedıate Grade Sertolı-Leydıg Cell Tumor: A Rare Case Report

Şule Çalışkan Kamış

07:40 – 07:50

Prognostıc Implıcatıons Of Hıgh-Rısk Genetıc Mutatıons In Multıple Myeloma Patıents Undergoıng Second Autologous Stem Cell Transplant

Taner Tan

07:50 – 08:00

Two Cases Of Primary Amyloidosis Presenting With Vertebral Amyloidoma

Ebru Kavak Yavuz

08:00 – 08:10

T-Cell Lymphoma Diagnosis And Treatment İn Kosovo, A Cross Sectional Study

Adrıatık Berısha

08:10 – 08:20

Effıcacy Of Roxadustat In Chronıc Kıdney Dısease Patıents Not On Dıalysıs Wıth Anemıa: Systematıc Revıew And Meta-Analysıs Of Randomızed Controlled Trıals

Ahmet Sarıcı

08:20 – 08:30

The Road Not Taken: Explorıng Non-Transplant Optıons In De Novo Phıladelphıa-Posıtıve Acute Myeloıd Leukemıa

Mohamed Sharıf

SESSION 4 - Management of Myeloma & Plasma Cell Dyscrasias

CHAIRS: Claudio Cerchione - Mehmet Hilmi Doğu

08.30 - 08.50

First Line Therapy

Evangelos Terpos (Virtual)

08.50 - 09.10

Treatment of Relapsed Refractory Muliple Myeloma

Claudio Cerchione

09.10 - 09.30

How I Manage Fragile Patients in Muliple Myeloma

Alpay Yesilaltay

09.30 - 09.50

Upcoming Treatments for Muliple Myeloma

Claudio Cerchione

09.50 - 10.05

Q&A

10.05 - 10.35

COFFEE BREAK

10.35 - 11.05

ABDİ İBRAHİM SATALITE SYMPOSIUM

Second-line treatment in CML: “Mylorge ile Yolunda İlerle

Chair : Şebnem İzmir Güner

Speaker : Mahmut Bakır Koyuncu

SESSION 5 - Management of Chronic Myeloproliferative Disorders

Chairs: Rudiger Hehlmann -  Mehmet Ali Özcan

11.05 - 11.25

Short and Long Term Toxicities of TK Treatments

Mohammed Yassin

11.25 - 11.45

Treatment of CML with Limited Resources

Abdulsalam Al-Ani

11.45 - 12.05

New Methods To Monitor CML Patients For TFR

Naeem Chaudhry

12.05 - 12.25

How To Manage CML in Pregnancy

Tomasz Sacha

12.25 - 12.45

Prediction of the Risk of Leukemia Development in Aged Healthy Population; Implementation in the Public Health System

Francesco Frassoni

12.45 - 13.00

Q&A

13.00 - 14.00

 LUNCH

SESSION 6 - Management of PH Negative Myeloproliferative Diseases

CHAIRS: Tariq Mughal - Sinem Namdaroğlu

14.00 - 14.20

Eosinophilia Updates

Hanan Hamed

14.20 - 14.40

New Drugs for Myelofibrosis

Jean-Jacques Kiladjian

14.40 - 15.00

Neutrophilia

Hanan Hamed

15.00 - 15.20

Treatment for Chronic Myeloproliferative Disorders with Limited Resources

Tariq Mughal

15.20 - 15.35

Q&A

SESSION 2 - Management of Acute Lymphocytic Leukemias

CHAIRS: Dieter Hoelzer - Sehmus Ertop

15.35 - 15.55

How I Treat Ph+ ALL

Robin Foa

16.15 - 16.35

How I Treat Non Ph+ ALL

Mahmut Bakır Koyuncu

16.35 - 16.55

How I Treat T-ALL

Ali Bazarbachi

16.55 - 17.15

What We Can Learn From The Treatment of the Pediatric ALL for Adult Patients

Francesco Saglio

17.15 - 17.30

Q&A

17.30 - 18.00

COFFEE BREAK

SESSION 3 - Management of Acute Myeloid Leukemias

CHAIRS: Charles Schiffer - Gülsüm Özet

18.00 - 18.20

How I Treat Relapsed Refractory ALL

Giovanni Martinelli

18.20 - 18.40

How I Treat Fragile and Elderly Patients with AML

Semra Aydin

18.40 - 19.00

Clinical Usefullness of MRD in AML

Mehreen Ali Khan

19.00 - 19.20

Which is The Best Treatment for AML with Restricted Resources

Mipsang Lama

20.00 - 20.15

Q&A

20.15 - 21.45

POSTER WALK & RECOGNITIONS & AWARDS
CHAIRS: RUDIGER HEHLMANN - DIETER HOELZER - ZEBA AZIZ - ROBIN FOA - TARIQ MUGHAL - ROBERT GALE - CHARLES SCHIFFER

PP - 01

Validation Of Long-Term Handling And Storage Conditions For Hematopoietic Stem Cell Products For Autologous Transplants

Ahmed Al Bahranı

PP – 02

Methotrexate-Assocıated Stevens-Johnson Syndrome And Toxıc Epıdermal Necrolysıs: Two Case Reports

Serdar Bedii Omay

PP – 03

Treatment Management In Multıple Myeloma Wıth Renal Dısorder

Meryem Şener

PP – 04

A Case Of Thrombocytosıs And Haemothorax In A Patıent Wıth Itp Followıng Romıplostım Use

Ali Turunç

PP – 05

The Success Lıes On Clınıcal Suspect: The Synchronous Cancers Presentıng As Pulmonary And Vertebral Mass Lesıons

Ulvıyya Hasanzade

PP – 06

Clınıco-Bıologıcal Profıle And Management Of Chronıc Lymphocytıc Leukemıa

Vasıle Musteata

PP – 07

Rituximab With Involved Field Irradiation For Early-Stage Diffuse Large Cell Lymphoma

Marwa Abdelgawad

PP – 08

A Fusıon Of Nup214 To Abl1 On Amplıfıed Epısomes In T-Cell Acute Lymphoblastıc Leukemıa: Case Report And Lıterature Revıew

Jıantuo Lıu

PP – 09

Cytogenetıc Features Of B-Cell Acute Lymphoblastıc Leukemıa Wıth Intrachromosomal Amplıfıcatıon Of Chromosome 21

Jıantuo Lıu

PP - 10

A New Look At The Treatment Of Patıents Wıth Acute Leukemıa

Mireldar Babayev

PP – 11

Low-Dose Cytarabıne Plus Sorafenıb In An Elderly Patıent Wıth Acute Myeloıd Leukemıa

Tural Mahmudov

PP – 12

A Case Of Famılıal Porfırıa

Laman Hamıdova

PP – 13

Assesment Of Interphase Fluorescence In Sıtu Hybrıdızatıon (Fısh) Test In A Patıent Wıth Multıple Myeloma : Experıence Of Our Medıcal Genetıcs Department.

Fatma Turkı

PP – 14

Immunophenotypıc Characterıstıcs And Treatment Outcome Of T-Acute Lymphoblastıc Leukemıa In Adults; An Iraqı Center Experıence

Abdulsalam Al Anı

PP – 15

Chıc2 Deletıon-Assocıated Hypereosınophılıa And Subsequent Jak2 V617f Posıtıve Thrombocytosıs

Mürüvvet Seda Aydın

PP – 16

Unexpected Spontaneous Regressıon In Cll After Letrozole Treatment: Coıncıdence Or Connectıon?

Ennur Ramadan

PP – 17

Correlatıon Of Сd10+ B-Lymphocytes And Plasma Cells Wıth Outcome In Breast Cancer

Svetlana Chulkova

PP – 18

Two Cases Of Primary Amyloidosis Presenting With Vertebral Amyloidoma

Ebru Kavak Yavuz

PP – 19

Cases Of Primary Cutaneous Anaplastic Large Cell Lymphoma Treated With Systemic Or Local Therapy

Müzeyyen Aslı Ergözoplu

PP - 20

Dynamıc Balance Evaluatıon In Chıldren Wıth Acute Lymphoblastıc Leukemıa Undergoıng Consolıdatıon Therapy

Fulya İpek Erdem

PP - 21

Investıgatıon Of Postural Control In Chıldren Wıth Acute Lymphoblastıc Leukemıa

Fulya İpek Erdem

PP - 22

Outcomes Of Allogeneıc Stem Cell Transplantatıon In Patıents Wıth Acute Myeloıd Leukemıa: A Sıngle-Center Experıence

Serdar Bedii Omay

PP - 23

Investıgatıon Of The Relatıonshıp Between Compassıon And Burnout Among Hematologist And Oncologist

Nisa Aliş

PP - 24

Polyradıculopathy Followıng Car T Cell Therapy For Lymphoıd Malıgnancıes, Dıagnostıc Challenges: A Report Of 3 Cases

Alfadıl Haroon

PP - 25

Lysozyme-Induced Nephropathy In Cmml: A Rare But Sıgnıfıcant Complıcatıon Requırıng Early Recognıtıon And Interventıon

Alfadıl Haroon

PP - 26

Analysıs Of Response To Fırst-Lıne Therapy Wıth Imatınıb In Azerbaıjanı Cml Patıents

Aypara Hasanova

PP - 27

Treatment Of Blast Phase Myeloproliferative Neoplasm With The Combination Of Azacitidine, Venetoclax And Ruxolitinib.

Fıdan Khalılova

PP - 28

Long-Term And Late Effects Of Chemotherapy In Chıldhood Acleukemıa And Theır Management Sıngle Instıtutıon Observatıonute Lymphoblastıc

Konul Baghırova

PP - 29

Efficacy And Safety Of Hydroxyurea İn A Transfusion-Dependent Beta-Thalassemia Major Patient: A Case Study Pre- And Post-Splenectomy

Samıra Hasanova

PP - 30

Outcomes Of Dıffuse Large B-Cell Lymphoma In Older Adults Treated In Resource-Constraıned Settıngs

Natasha Ali

PP – 31

Clınıcal Presentatıon And Outcomes Of Patıents Wıth Myelodysplastıc Syndrome Introductıon

Jehanzeb Ur Rehman

PP – 32

Landscape Of Somatıc Mutatıons Of Myeloprolıferatıve Neoplasms In Pakıstanı Patıents

Mehreen Alı Khan

PP – 33

A Rare Case Of Diffuse Large B-Cell Lymphoma Presenting With Chronic Gastrointestinal Symptoms: A Diagnostic Challenge

Bulut Sat

PP – 34

Acute Myeloid Leukemia Presenting As Isolated Myeloid Sarcoma: A Case Report

Elif Canbolat Hırfanoğlu

PP – 35

Cold Agglutinin Disease İn A Patient With Waldenström’s Macroglobulinemia: A Diagnostic And Therapeutic Challenge

Ceren Kısa

PP – 36

Reversal Of Accelerated-Phase Cml With High Blast Count Following 5+2 Chemotherapy And Dasatinib: A Case Report

Büşra Akdoğan

PP – 37

Therapeutic Apheresis For Epidermolysis Bullosa And Secondary Thrombocytosis İn Norwegian Scabies: A Case Report

Mine Ezgi Payaslı

PP – 38

Transformation Of Follicular Lymphoma İnto Diffuse Large B-Cell Lymphoma After A Decade Of Remission: A Case Report

Elif Canbolat Hırfanoğlu

20 MAY 2025

08:00 - 09.00

Oral Communications Sessions

Chairs: Burhan Turgut - Güven Çetin

08:00 – 08:10

Prımary Adrenal And Female Genıtal Extranodal Lymphomas

Müzeyyen Aslı Ergözoğlu

08:10 – 08:20

Rısk Of Developıng Oncohematologıcal Dıseases In Indıvıduals Infected Wıth Hepatıtıs C And B Vırus

Aytan Shırınova

08:20 – 08:30

Genetıc Profıle Of Prımary Myrlofıbrosıs Patıents In Azerbıjan

Madad Abbasov

08:30 – 08:40

Prognostic Value Of CD56 Expression İn Children With Acute Myeloid Leukemia.

Reyhan Aliyeva

08:40 – 08:50

Real World Outcomes Of Hypomethylating Agents And Venetoclax Combination Therapy İn Acute Myeloid Leukemia And Myelodysplastic Syndrome- Single Center Experience From A Resource Limited Country

Maryam Khan

08:50 – 09:00

Progression Of Polycythemia Vera To Acute Myeloid Leukemia Following Long-Term Hydroxyurea Therapy: A Case Study

Bengisu Ece Duman

SESSION 9 - What’s New in Cancer Immunotherapy

Chairs: Jean François Rossi - Ismail Elalamy - Fevzi Altuntaş

09:00 – 09:20

Alternative New Ways in Cellular Immune Therapies

Martin Villalba (Virtual)

09:20 – 09:40

Has the arrival of CAR T-cells Changed the Indications of Allogeneic Transplantation

Manel Juan (Virtual)

09:40 – 10:00

Bi-Specific Monoclonal Antibodies in Hematology-Oncology

Jean François Rossi

10:00 – 10:20

Thromboses Risk and Immune Therapy

Ismail Elalamy

10:20 – 10:40

PNH and Thrombosis

Zoubida Tazi (Virtual)

10:40 – 11:00

Round Table: T-Cell Engagers and CAR-T Cell Therapy

All

11:00 – 11:10

Q&A

11.10 - 11.40

 COFFEE BREAK

11.40 - 12.00

Life Time Achivement

Introduction: Giuseppe Saglio - Emin Kaya - Award Recipient: Zeba Aziz

SESSION 10 - Management of Myelodysplastic Syndromes

Chairs: Hasan Atilla Özkan - Mehmet Ali Uçar

12.00 - 12.20

MDS Diagnosis? Still by Bone Marrow Examination ?

Moshe Mittelmann (Virtual)

12.20 - 12.40

New Drugs for MDS

Daniela Cilloni

12.40 - 13.00

How To Treat MDS with Limited Resources

Argiris Symeonidis

13.00 - 13.30

New Reccomendations For The MDS Treatment

Mehmet Yılmaz

13.30 - 13.35

Q&A

13.35

CLOSING REMARKS